Evaluation of the Pharmacokinetics and Pharmacodynamics of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infections Using Data from Two Phase 2 Clinical Studies

The pharmacokinetic-pharmacodynamic (PK-PD) relationships between serum exposure measures of liposomal amikacin for inhalation (LAI) and the change in pulmonary function test (PFT) measures and number of CFU from baseline were evaluated in cystic fibrosis (CF) patients chronically infected with Pseu...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Okusanya, Olanrewaju O., Bhavnani, Sujata M., Hammel, Jeffrey P., Forrest, Alan, Bulik, Catharine C., Ambrose, Paul G., Gupta, Renu
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2014
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135881/
https://ncbi.nlm.nih.gov/pubmed/24687506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02421-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky